A2 Bio will present a poster at the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) Tandem Meetings on February 13, 2025 in Honolulu, Hawaii. The poster, titled "Recommendations for Defining Chimeric Antigen Receptor T cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Stage CAR T Therapy Studies", is a collaboration of A2 Bio with an expert panel of academic cell therapists to recommend DLT definitions for early-phase cell therapy studies. Please join A2 Bio, along with Sarah Nikiforow, MD, PhD, Technical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute, at Poster ID 611 in Exhibit Hall 3 (HCC) on Thursday, 13 February 2025 at 6:45 pm HST. For more information on A2 Bio's publications, please visit: https://lnkd.in/g8CiubqZ For more information on our clinical studies, please visit: https://lnkd.in/ge7KqZ8T #Tandem25 #A2Bio #Tmod #CellTherapy #CART
